ArticleThe Role of Interleukin-17 and Toll-Like Receptor 4 Gene Polymorphisms in Patients with Hepatitis C Virus and Hepatocellular Carcinoma
ArticleThe Role of Interleukin-17 and Toll-Like Receptor 4 Gene Polymorphisms in Patients with Hepatitis C Virus and Hepatocellular Carcinoma
ArticleRelation between Interleukin -4 (590C/T) Gene Polymorphism and Hepatocellular Carcinoma Risk in HBV and HCV Patients
ArticleRelation between Interleukin -4 (590C/T) Gene Polymorphism and Hepatocellular Carcinoma Risk in HBV and HCV Patients
ArticleRole of High Mobility Group Box1 in Pathogenesis of Hepatitis C Virus induced Hepatocellular Carcinoma
ArticleRole of High Mobility Group Box1 in Pathogenesis of Hepatitis C Virus induced Hepatocellular Carcinoma
ArticleGenetic Polymorphism in the Human IL-10 and Human IL-28 B with Increased Risk of Hepatitis B Virus Infection
ArticleGenetic Polymorphism in the Human IL-10 and Human IL-28 B with Increased Risk of Hepatitis B Virus Infection
ArticleInterleukin-9: Investigating its possible role in liver cirrhosis progression and in tumour promotion of hepatocellular carcinoma in chronic HCV infected patients, A single centre study
ArticleInterleukin-9: Investigating its possible role in liver cirrhosis progression and in tumour promotion of hepatocellular carcinoma in chronic HCV infected patients, A single centre study
ArticleROLE OF INTERLEUKIN-17 IN THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C VIRUS LIVER CIRRHOSIS
ArticleROLE OF INTERLEUKIN-17 IN THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C VIRUS LIVER CIRRHOSIS
ArticleRole of MICA rs2596542 and IFN-gamma rs2069727 Polymorphism in HCC Development in Egyptian Patients with HCV-related HCC
ArticleRole of MICA rs2596542 and IFN-gamma rs2069727 Polymorphism in HCC Development in Egyptian Patients with HCV-related HCC
ArticleInterleukin-27 levels and its Polymorphism in Hepatocellular carcinoma associated with Hepatitis C
ArticleInterleukin-27 levels and its Polymorphism in Hepatocellular carcinoma associated with Hepatitis C
ArticleEvaluation of toll-like receptor 4 polymorphism in patients with hepatitis c virus-induced hepatocellular carcinoma
ArticleEvaluation of toll-like receptor 4 polymorphism in patients with hepatitis c virus-induced hepatocellular carcinoma